Lencer A., 20

Lencer Adhiambo is a 20-year-old young woman and a mother of one child. She lives with her father, who has been a widower since the passing of her mother many years ago. Lencer is the firstborn in a family of four siblings, three of whom are still in school, struggling to continue their education due to the family’s difficult circumstances. Her father is a small-scale farmer who relies on a modest farm near their home in a rural village to support the entire household, including Lencer and her child. The income from the farm is limited and often insufficient to meet the family’s needs. Lencer has been living with sickle cell disease and has faced recurrent illness from a young age. Due to frequent episodes of sickness and lack of adequate medical support, she dropped out of school at the age of thirteen. Now at twenty, she continues to struggle with her condition, often unable to access the recommended treatment because of financial constraints. Both she and her child depend entirely on her father, who is unable to meet the medical expenses required for her care. Lencer was brought to the facility in a very weak condition, assisted by a stranger who helped transport her on a motorbike while she carried her young child. She was unable to walk on her own and was immediately received in a wheelchair and attended to by the medical team. She was in severe distress, crying and complaining of intense pain in both knee joints. Given her known history of sickle cell disease and her critical condition, she was promptly assessed and deemed in need of urgent admission to stabilize her and manage the pain crisis. At the time, she had no means to cater for her treatment, and when her father was contacted, he also expressed inability to raise the required funds. In view of her situation, the attending doctor introduced her to Helpster Charity which stepped in to support her with the necessary medical care and treatment, after having been assessed by the social worker and confirmed to be indeed under privileged.

The patient was admitted on 15th March with complaints of severe generalized body pains, particularly in the joints and limbs, accompanied by weakness and reduced mobility. Clinical evaluation confirmed a vaso-occlusive crisis in a known sickle cell disease patient. Treatment was initiated promptly with intravenous fluids and injectable medications including cef, tramadol, and diclofenac to manage pain and prevent infection. The patient was closely monitored, and supportive oral therapy with folic acid, hydroxyurea, and relcergel syrup was started. Laboratory investigations (FHG and malaria test) were performed, and results helped guide continued management. By the second day of admission, the patient showed notable improvement, with reduced pain intensity and improved mobility. Hydration status improved, and the patient was able to tolerate oral medications well. By 18th March, the patient had stabilized significantly, with minimal pain and good general condition. The patient was discharged on oral medications including folic acid, amoxyl, and relcergel syrup, with advice on maintaining hydration, avoiding known triggers, and attending regular follow-up clinics. The recovery was smooth, and the patient was expected to continue improving at home with adherence to the prescribed treatment.

Lencer presented with a sickle cell crisis, evidenced by severe bilateral joint pain, marked weakness, and inability to walk. This is a serious and painful complication of Sickle Cell Disease, often triggered by factors such as dehydration, infection, or stress. Given her clinical state and background of recurrent illness without consistent access to care, immediate admission was necessary. She has been started on appropriate management, including pain control, hydration, oxygen support as needed, and monitoring for possible complications such as infection or severe anemia. Her condition requires close observation to ensure stabilization and prevent further deterioration. Lencer’s prognosis is guarded but manageable. With timely and appropriate treatment, most sickle cell crises can be controlled, and patients can recover from the acute episode. However, due to her history of limited access to consistent care and recurrent crises, she remains at risk of future episodes and complications. With proper follow-up, regular medical care, good nutrition, and access to recommended therapies, her quality of life can significantly improve